Jacobo Mintzer

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi request reprint Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease
    K Ranga Rama Krishnan
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Am J Psychiatry 160:2003-11. 2003
  2. ncbi request reprint The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials
    Ira Katz
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA, and Department of Neurology, Memory Clinic, Middelheim Hospital, ZNA, Wilrijk Antwerp, Belgium
    Int J Geriatr Psychiatry 22:475-84. 2007
  3. ncbi request reprint Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial
    Anton P Porsteinsson
    Alzheimer s Disease Care, Research and Education Program, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14620, USA
    Curr Alzheimer Res 5:83-9. 2008
  4. ncbi request reprint Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial
    Jacobo Mintzer
    Department of Psychiatry and Behavioral Sciences, VA Medical Center, Medical University of South Carolina, Charleston, 29406, USA
    Am J Geriatr Psychiatry 14:280-91. 2006
  5. ncbi request reprint A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease
    Stephanie Kirbach
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA
    Clin Drug Investig 28:291-303. 2008
  6. ncbi request reprint The many faces of psychosis in the elderly
    Jessica Broadway
    Adult and Geriatric Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
    Curr Opin Psychiatry 20:551-8. 2007
  7. ncbi request reprint Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study
    Ziad Nahas
    Brain Stimulation Laboratory, Institute of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
    Depress Anxiety 19:249-56. 2004
  8. ncbi request reprint Psychosis in elderly patients: classification and pharmacotherapy
    Jacobo Mintzer
    Medical University of South Carolina, Institute of Psychiatry, Charleston 29406, USA
    J Geriatr Psychiatry Neurol 16:199-206. 2003
  9. ncbi request reprint Elderly veterans with combat-related posttraumatic stress disorder in specialty care
    B Christopher Frueh
    Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina 29401, USA
    J Nerv Ment Dis 192:75-9. 2004
  10. ncbi request reprint Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort
    Mark T Wagner
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, United States
    Arch Clin Neuropsychol 22:405-14. 2007

Detail Information

Publications14

  1. ncbi request reprint Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease
    K Ranga Rama Krishnan
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Am J Psychiatry 160:2003-11. 2003
    ..The authors examined the effect of the acetylcholinesterase inhibitor donepezil on magnetic resonance markers of neurodegeneration in Alzheimer's disease...
  2. ncbi request reprint The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials
    Ira Katz
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA, and Department of Neurology, Memory Clinic, Middelheim Hospital, ZNA, Wilrijk Antwerp, Belgium
    Int J Geriatr Psychiatry 22:475-84. 2007
    ..Psychosis of Alzheimer's disease (AD) is a specific component of AD, characterized by delusions, misidentifications, and hallucinations...
  3. ncbi request reprint Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial
    Anton P Porsteinsson
    Alzheimer s Disease Care, Research and Education Program, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14620, USA
    Curr Alzheimer Res 5:83-9. 2008
    ..To evaluate the efficacy and safety of memantine in patients with mild to moderate Alzheimer's disease (AD) receiving cholinesterase inhibitor (ChEI) treatment...
  4. ncbi request reprint Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial
    Jacobo Mintzer
    Department of Psychiatry and Behavioral Sciences, VA Medical Center, Medical University of South Carolina, Charleston, 29406, USA
    Am J Geriatr Psychiatry 14:280-91. 2006
    ..The objective of this study was to evaluate efficacy and safety of low-dose risperidone for treating psychosis of Alzheimer disease (AD)...
  5. ncbi request reprint A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease
    Stephanie Kirbach
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA
    Clin Drug Investig 28:291-303. 2008
    ..In this study we set out to compare the expected costs and outcomes for a community-dwelling cohort of patients with Alzheimer's disease with agitation and/or psychosis who are (a) untreated, or (b) treated with olanzapine...
  6. ncbi request reprint The many faces of psychosis in the elderly
    Jessica Broadway
    Adult and Geriatric Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
    Curr Opin Psychiatry 20:551-8. 2007
    ..As the population ages, the number of older patients with psychosis will greatly rise. This review focuses on the etiology, biologic and clinical findings, and treatments of common causes of psychosis in the elderly...
  7. ncbi request reprint Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study
    Ziad Nahas
    Brain Stimulation Laboratory, Institute of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
    Depress Anxiety 19:249-56. 2004
    ....
  8. ncbi request reprint Psychosis in elderly patients: classification and pharmacotherapy
    Jacobo Mintzer
    Medical University of South Carolina, Institute of Psychiatry, Charleston 29406, USA
    J Geriatr Psychiatry Neurol 16:199-206. 2003
    ..The authors review common diagnostics associated with psychosis in the elderly and clinical guidelines to selecting antipsychotic pharmacotherapy...
  9. ncbi request reprint Elderly veterans with combat-related posttraumatic stress disorder in specialty care
    B Christopher Frueh
    Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina 29401, USA
    J Nerv Ment Dis 192:75-9. 2004
  10. ncbi request reprint Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort
    Mark T Wagner
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, United States
    Arch Clin Neuropsychol 22:405-14. 2007
    ....
  11. ncbi request reprint Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial
    Pierre N Tariot
    Department of Psychiatry, The Center for Aging and Developmental Biology, Univ of Rochester Medical Center, Rochester, NY, USA
    Am J Geriatr Psychiatry 13:942-9. 2005
    ..It addresses the efficacy, safety, and tolerability of divalproex sodium for the treatment of agitation associated with dementia...
  12. ncbi request reprint Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
    Michael Grundman
    Alzheimer s Disease Cooperative Study, Department of Neurosciences, University of California San Diego, 8950 Villa La Jolla Drive, Suite 227, La Jolla, CA 92037, USA
    Arch Neurol 61:59-66. 2004
    ..The Memory Impairment Study (MIS) is a multicenter clinical trial in patients with MCI designed to evaluate whether vitamin E or donepezil is effective at delaying the time to a clinical diagnosis of AD...
  13. ncbi request reprint Dementia with Lewy bodies
    Ian McKeith
    Institute for Ageing and Health, University of Newcastle, Newcastle upon Tyne, UK
    Lancet Neurol 3:19-28. 2004
    ..Clear guidance on the management of DLB is urgently needed. Virtually unrecognised 20 years ago, DLB could within this decade be one of the most treatable neurodegenerative disorders of late life...
  14. doi request reprint Disease-modifying therapies in Alzheimer's disease
    Stephen Salloway
    Department of Clinical Neuroscience, Division of Biology and Medicine, Brown Medical School, Providence, RI, USA
    Alzheimers Dement 4:65-79. 2008
    ..Potentially neuroprotective and restorative treatments such as neurotrophins, neurotrophic factor enhancers, and stem cell-related approaches are also under investigation...